CervoMed Inc (CRVO) Price Prediction & ForecastCRVOCervoMed Inc

Alphio's CRVO stock price prediction model matches the current CervoMed Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.43 (+1.65%). The 1-week path is $1.52 (+7.66%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

CervoMed Inc. is not a good buy right now due to its extremely low RSI of 11.45, indicating oversold conditions, and a significant year-to-date decline of 81.90%. While the gross margin is high at 100% for the last reported quarters, the company is facing severe financial challenges with a net income loss of -$7,964,158 in Q1 2026. The stock's recent performance shows a 5-day change of -11.88%, and it is currently trading at $1.41, far below its 52-week high of $10.00, indicating a lack of investor confidence and potential volatility ahead. The main risk is the ongoing financial losses and the uncertainty surrounding future financing and partnerships for clinical trials, which could further impact stock performance negatively.

CervoMed Inc (CRVO) last closed at $1.41, losing -2.76%. These facts feed the 1-day and 1-week CRVO price prediction above.